Dr Maria Tenpenny @DrMariaTenpenny - Twitter Profile

18 minutes ago

🚨 ONE DEWORMER. 20+ CANCER TYPES. WHY IS FENBENDAZOLE GETTING SO MUCH ATTENTION? Fenbendazole is a benzimidazole-class antiparasitic drug widely used in veterinary medicine. But in recent years, it has attracted attention for a very different reason: cancer research. 🧬 THE CANCER TYPES BEING STUDIED Preclinical research has explored Fenbendazole in a wide range of cancer models, including: • Hodgkin lymphoma • Non-Hodgkin lymphoma • Melanoma • Breast cancer • Neuroendocrine tumors • Lung cancer • Liver cancer • Ovarian cancer • Pancreatic cancer • Endometrial cancer • Glioblastoma • Astrocytoma • Medulloblastoma • Head and neck cancer • Esophageal cancer • Colorectal cancer • Adrenal cancer • Renal cancer • Bladder cancer • Prostate cancer • Leukemia • Myelofibrosis • Various sarcomas That’s more than 20 cancer types represented across the research landscape. But the real question isn’t simply how many cancer types have been studied. It’s how Fenbendazole might affect cancer biology. 🔬 POSSIBLE MECHANISMS UNDER INVESTIGATION * Microtubule disruption Microtubules play an essential role in cell structure and division. Research has investigated whether Fenbendazole can interfere with these processes. * Apoptosis Studies have examined whether Fenbendazole may promote programmed cell death in certain cancer models. * Glucose metabolism Because cancer cells can have altered metabolic demands, researchers have investigated whether Fenbendazole can affect glucose uptake and related metabolic pathways. * P53 signaling The tumor-suppressor protein p53 is important in regulating cell growth and damaged cells. Fenbendazole has also been investigated for potential effects involving this pathway. So the scientific question is more specific than: “Can a deworming drug affect cancer?” The question is: Could Fenbendazole interfere with multiple biological processes that cancer cells depend on? That’s what makes the research interesting. 🧬 WHY THE INTEREST? ✓ Research has explored multiple tumor types ✓ Multiple studies and publications have investigated Fenbendazole in cancer models ✓ Several potential biological mechanisms are being examined ✓ Drug repurposing could potentially offer new avenues for cancer research One established antiparasitic. Multiple cancer models. Several biological pathways. Microtubules. Apoptosis. Glucose metabolism. P53. The Fenbendazole story is attracting increasing scientific and public attention—but most of the evidence remains preclinical, and it has not been established as a proven cancer treatment in humans. The bigger question remains: Could this old antiparasitic have a much bigger story to tell in cancer research? The science will ultimately determine how far this idea can go. #Fenbendazole #CancerResearch #DrugRepurposing #CancerScience #Ivermectin

DrMariaTenpenny's tweet photo. 🚨 ONE DEWORMER. 20+ CANCER TYPES. WHY IS FENBENDAZOLE GETTING SO MUCH ATTENTION?

Fenbendazole is a benzimidazole-class antiparasitic drug widely used in veterinary medicine. But in recent years, it has attracted attention for a very different reason: cancer research.

🧬 THE CANCER TYPES BEING STUDIED

Preclinical research has explored Fenbendazole in a wide range of cancer models, including:

• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Melanoma
• Breast cancer
• Neuroendocrine tumors
• Lung cancer
• Liver cancer
• Ovarian cancer
• Pancreatic cancer
• Endometrial cancer
• Glioblastoma
• Astrocytoma
• Medulloblastoma
• Head and neck cancer
• Esophageal cancer
• Colorectal cancer
• Adrenal cancer
• Renal cancer
• Bladder cancer
• Prostate cancer
• Leukemia
• Myelofibrosis
• Various sarcomas

That’s more than 20 cancer types represented across the research landscape.

But the real question isn’t simply how many cancer types have been studied.

It’s how Fenbendazole might affect cancer biology.

🔬 POSSIBLE MECHANISMS UNDER INVESTIGATION

* Microtubule disruption

Microtubules play an essential role in cell structure and division. Research has investigated whether Fenbendazole can interfere with these processes.

* Apoptosis

Studies have examined whether Fenbendazole may promote programmed cell death in certain cancer models.

* Glucose metabolism

Because cancer cells can have altered metabolic demands, researchers have investigated whether Fenbendazole can affect glucose uptake and related metabolic pathways.

* P53 signaling

The tumor-suppressor protein p53 is important in regulating cell growth and damaged cells. Fenbendazole has also been investigated for potential effects involving this pathway.

So the scientific question is more specific than:

“Can a deworming drug affect cancer?”

The question is:

Could Fenbendazole interfere with multiple biological processes that cancer cells depend on?

That’s what makes the research interesting.

🧬 WHY THE INTEREST?

✓ Research has explored multiple tumor types

✓ Multiple studies and publications have investigated Fenbendazole in cancer models

✓ Several potential biological mechanisms are being examined

✓ Drug repurposing could potentially offer new avenues for cancer research

One established antiparasitic.
Multiple cancer models.
Several biological pathways.

Microtubules. Apoptosis. Glucose metabolism. P53.

The Fenbendazole story is attracting increasing scientific and public attention—but most of the evidence remains preclinical, and it has not been established as a proven cancer treatment in humans.

The bigger question remains:

Could this old antiparasitic have a much bigger story to tell in cancer research?

The science will ultimately determine how far this idea can go.

#Fenbendazole #CancerResearch #DrugRepurposing #CancerScience #Ivermectin

0

3

0

12

Dr Maria Tenpenny

@DrMariaTenpenny

Last Seen Users on Sotwe

Trends for you

Most Popular Users